This notice is to make the general public aware that Waterfront SICAV plc (“the Scheme”) recently requested the Malta Financial Services Authority (“MFSA”) to accept the surrender of the collective investment scheme licence granted in relation to Best Biotech Fund (“the Sub-Fund”). The MFSA has accepted the Scheme’s request. This surrender is entirely voluntary and does not arise as a result of any regulatory action taken by the MFSA. Accordingly, with effect from 7 September 2017, the SubFund ceased to be licensed by the MFSA.

MFSA Ref: 84-2017